Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells

enthalten in: Clinical epigenetics | 2022

von Zwergel, C. | Schnekenburger, M. | Sarno, F. | +18

Correction to: Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis

enthalten in: European journal of clinical pharmacology | 2022

von Tempestilli, M. | Stazi, G. | Maffongelli, G. | +6

Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis

enthalten in: European journal of clinical pharmacology | 2021

von Tempestilli, M. | Stazi, G. | Maffongelli, G. | +6

Altered mitochondrial function in cells carrying a premutation or unmethylated full mutation of the FMR1 gene

enthalten in: Human genetics | 2020

von Nobile, V. | Palumbo, F. | Lanni, S. | +17

Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells

enthalten in: Clinical epigenetics | 2019

von Zwergel, C. | Schnekenburger, M. | Sarno, F. | +18

Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor Agent

enthalten in: Journal of medicinal chemistry | 2016

von Thaler, F. | Mattevi, A. | Marrocco, B. | +14

LSD1 inhibitors: a patent review (2010-2015)

enthalten in: Expert opinion on therapeutic patents | 2016

von Stazi, G. | Zwergel, C. | Valente, S. | +1

Renal replacement therapy in neonates with congenital heart disease

enthalten in: Contributions to nephrology | 2007

von Morelli, S. | Ricci, Z. | Di Chiara, L. | +6